The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Now these people need Deepverges fully integrated Microtox PD solution
https://www.abc.net.au/news/2021-08-15/nt-covid-waterwater-testing-in-darwin-crocodile-watch/100365226
Don’t get me wrong TRat as I’m a strong believer in DVRG and it makes up 20% of my portfolio...
... but small sample size so far, wouldn’t be able to call it numerically significant. Also no timelines for continuation of ph3. Hopefully there is an interview/ post to give more clarity.
Encouraging, but further behind commercialisation and timeline than I thought.
Shame no update on PT either.
I’ve been thinking about it this way for a while, the none inclusion of Covid-19 revenues in the annual projection led me to think this might be the approach.
Clearly selling at cost is different to no revenue but from a planning perspective it would make sense to exclude on this basis if the commercial model isn’t declared.
Another option would be you charge private companies/gov for the readers as it’s in their interest to open up but the breathalyser element is free for penetration, recurring revenue on the chips. That would be the most lucrative for Dvrg to my mind.
Unless the money is in the chips and recurring revenue, you ship the reader units and breathalyser at cost for market penetration/take up?
Not the worst idea.
Simple answer is..... it depends.
Could be an all cash offer, in which case shareholders get bought out or could be an all share offer where shareholders move to owning shares in the acquirer at an agreed conversion rate. Could also be a combo of the two...
Water genius,
It’s clear you have an agenda based on posting history, and as eluded to by yourself and others likely a personal link to MW/Dvrg.
All I would say that is if you are making accusations of ‘fraudulent behaviour’ and have ‘evidence’ then I ask that you share it for as you say we should be ‘heeding your warning’ if once the evidence is seen, shareholders agree with your statements. If you don’t/can’t share it then probably best to leave out the accusations and slander towards the company, and save your own time and the time of others by not posting here anymore. Sound fair?
Good synopsis Paul that’s my view on current state as well. I previously thought fair value was around 40p but I this Rev update places it more like 50p with SkinTrust and BT as upside past that.
I’ve been lurking Chesh don’t worry, just waiting for the news!
From a financial perspective I understand the commission (although structure, how much etc obvs tbc), It’s that role the product plays in our ecosystem, like you that link and how it might feed into Microtox BT/PT or even Labskin is where I’m lost. Hopefully GB makes it all clear shortly.
Great RNS, and surely COVID update to come with SkinTrust just around the corner.
The last bullet in the RNS:
· Microsaic's in-line bio-processing monitoring unit[vii], announced in the RNS[viii] of the 15th of February, will fully automate the upstream quality control system removing all manual testing requirements.
Does anyone have a view on how this installment works and what this means for DVRG holders aside from the benefits of a great bit of kit adding value to the overall offering? I’m trying to understand where else we might see it crop up.
I don't think so Dafad. I'm Australia based and this is fairly common news over here, from what I can tell it looks to be manual testing 'below ground' but there certainly is a rigour and framework to the testing which has proved effective. I'll be sure to report back if I see any sign of DVRG involvement (or if GB needs a sales rep ;) )
https://www.bloomberg.com/news/videos/2020-12-09/virus-found-on-cruise-to-nowhere-video
If only they had DVRG's integrated solution...
https://www.bloomberg.com/news/videos/2020-12-09/virus-found-on-cruise-to-nowhere-video
If only they had DVRG's integrated solution...
Thanks Chesh, I've been keeping an eye there but hadn't seen anything coming up. I assumed given it's the 1st Dec and thats a week out it would have been shared.
Hopefully a nice steady rise to the low 30's ahead of the meeting, this last month has been completely unwarranted and tough to witness.
Apologies if I've missed this, but does anyone have the link for the webinar next week?
Thanks in advance.
OBT - per the HL FAQ's my understanding is:
What happens if I accept the Offer?
If you accept the Offer at this opportunity your holding will be removed from your account and sent off in acceptance of the Offer. On or around 17 November 2020 the Company will make an announcement as to the acceptance level of the Takeover and whether it has been declared “wholly unconditional” (i.e. successful).
If I accept the Offer when will I receive my proceeds?
Once the Offer is declared 'wholly unconditional' (i.e. successful), the relevant consideration will be credited to your account within 14 calendar days.
So essentially your shares are frozen until offer outcome is known.